Celia Economides

Biography

Celia has over 15 years of experience in the life sciences and biotech industries, spanning communications, investor relations, finance, patient advocacy, marketing and clinical development. In her role at Aurinia, she leads the company's communications, advocacy and investor relations efforts. She most recently served as a Director in Global Medical Affairs at BioMarin Pharmaceutical, Inc, where she led both patient advocacy and competitive intelligence efforts focusing on Duchenne Muscular Dystrophy. Previously, she led IR & Corporate Communications at Prosensa, which was acquired by BioMarin in January 2015. Prior to joining Prosensa, Celia was Director of IR & Program Development at the Biotechnology Innovation Organization (BIO), where she was responsible for BIO’s outreach to the investment community and working with emerging companies to improve their communications and partnering activities. She led the program development at BIO’s annual investor and BD conferences and provided industry research used in BIO’s policy and advocacy activities. Prior to BIO, Celia worked at a $2B healthcare focused hedge fund and in financial services focusing on the biotech sector. She began her career working in clinical research at Columbia University. She holds a Bachelor of Arts (BA) degree from McGill University and a Master’s in Public Health (MPH) from Columbia University.

Research Interest

Clinical research